Rebamipide 100mg

DRUG3 trials

Sponsors

Chong Kun Dang Pharmaceutical, Pirogov Russian National Research Medical University, Tanta University

Conditions

Atrial Fibrillation (AF)GastritisRheumatoid Arthritis (RA)

Phase 2

Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet

CompletedNCT03437785

Chong Kun Dang PharmaceuticalGastritis

Start: 2018-01-16End: 2018-10-12Updated: 2018-10-31

Clinical Study Comparing Diosmin vs Rebamipide as Adjuvant Therapies vs Conventional Therapy in Patients With Rheumatoid Arthritis

RecruitingNCT07745426

Tanta UniversityRheumatoid Arthritis (RA)

Start: 2026-08-01End: 2027-08-01Target: 66Updated: 2026-08-04

Phase 4

Gastroprotective Efficacy of Rebamipide in Patients With Atrial Fibrillation Treated With DOACs

CompletedNCT07354230

Pirogov Russian National Research Medical UniversityAtrial Fibrillation (AF)

Start: 2022-01-11End: 2024-09-20Updated: 2026-01-21

Related Papers

A Phase 2, Multi‐Center, Randomized, Double‐Blind, Parallel‐Group Trial to Evaluate the Efficacy and Safety of CKD‐495 in Patients With Acute and Chronic Gastritis

Canadian Journal of Gastroenterology and Hepatology2025-01-012 citations

Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial

Medicine2023-12-085 citations